B. Fisher

发表

The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27.

D. Wickerham, N. Wolmark, H. Bear, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.

Anna L. Brown, J. Bryant, D. Wickerham, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18.

J. Bryant, N. Wolmark, E. Mamounas, 2001, Journal of the National Cancer Institute. Monographs.

Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials

J. Bryant, N. Wolmark, B. Fisher, 2004, The Lancet.

Tamoxifen for early breast cancer: an overview of the randomised trials

Mike Clarke, Luc Bijnens, Michael Gnant, 1998, The Lancet.

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.

C K Redmond, B Fisher, C. Redmond, 1999, Journal of the National Cancer Institute.

Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less.

Norman Wolmark, James J Dignam, Soonmyung Paik, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Y Wang, Mike Clarke, Donald A. Berry, 2005, The Lancet.

A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors.

C. Redmond, J. Costantino, D. Wickerham, 1989, The New England journal of medicine.

Pathobiology of preoperative chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel (NSABP) protocol B-18.

J. Bryant, N. Wolmark, B. Fisher, 2002, Cancer.

Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer.

B Fisher, J. Bryant, D. Wickerham, 1997, Journal of the National Cancer Institute.

Number of lymph nodes examined and the prognosis of breast carcinoma.

B. Fisher, N. Slack, Slack Nh, 1970, Surgery, gynecology & obstetrics.

Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer.

B Fisher, C. Redmond, N. Wolmark, 1985, The New England journal of medicine.

Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial

James Dignam, Norman Wolmark, Mirsada Begovic, 1999, The Lancet.

Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors.

B Fisher, J Costantino, C. Redmond, 1996, Journal of the National Cancer Institute.

Lumpectomy for breast cancer: an update of the NSABP experience. National Surgical Adjuvant Breast and Bowel Project.

C. Redmond, B. Fisher, 1992, Journal of the National Cancer Institute. Monographs.

Effects of tamoxifen on benign breast disease in women at high risk for breast cancer.

S. Paik, J. Costantino, D. Wickerham, 2003, Journal of the National Cancer Institute.

Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer.

E. Mamounas, B. Fisher, J. Dignam, 2003, Journal of the National Cancer Institute.

Duration of adjuvant tamoxifen therapy.

J. Bryant, B. Fisher, J. Dignam, 2001, Journal of the National Cancer Institute. Monographs.

Coronary heart disease mortality and adjuvant tamoxifen therapy.

L. Kuller, J. Costantino, B. Fisher, 1997, Journal of the National Cancer Institute.

Contributions to the understanding and management of breast cancer. Steiner award lecture 1992

B. Fisher, 1993, International journal of cancer.

New perspective on cancer of the contralateral breast: a marker for assessing tamoxifen as a preventive agent.

C. Redmond, B. Fisher, 1991, Journal of the National Cancer Institute.

Effect of tamoxifen on serum insulinlike growth factor I levels in stage I breast cancer patients.

C. Redmond, C. Polychronakos, J. Costantino, 1990, Journal of the National Cancer Institute.

Adjuvant Therapy for Node-Negative Breast Cancer

I. Tannock, C. Redmond, R. Gelber, 1989 .

Juvant Tamoxifen Therapy for Breast Cancer. Note

B. Fisher, E. Fisher, L. Rutqvist, 2022 .

A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors.

C. Redmond, R. Foster, D. Wickerham, 1989, The New England journal of medicine.

Prognosis and treatment of patients with breast tumors of one centimeter or less and negative axillary lymph nodes.

N. Wolmark, B. Fisher, E. Fisher, 2001, Journal of the National Cancer Institute.

Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of findings from NSABP B-19 comparing methotrexate and

C. Redmond, J. Costantino, D. Wickerham, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

Terry L. Smith, R. Collins, L. Holmberg, 1998, Lancet.

Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy.

M Baum, J Cuzick, B Fisher, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

National Surgical Adjuvant Breast and Bowel Project breast cancer prevention trial: a reflective commentary.

B. Fisher, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Increased intensification and total dose of cyclophosphamide in a doxorubicin-cyclophosphamide regimen for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-22.

D. Wickerham, N. Wolmark, F. Meyers, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Ivanov, Harris, R. Collins, 2005, The Lancet.

Pathologic findings from the national surgical adjuvant breast project (NSABP) protocol B‐17. Intraductal carcinoma (ductal carcinoma in situ)

Joseph Costantino, C. Redmond, J. Costantino, 1995, Cancer.

Overview of randomized trials comparing radical mastectomy without radiotherapy against simple mastectomy with radiotherapy in breast cancer.

J Cuzick, B Fisher, R Peto, 1987, Cancer treatment reports.

Adjuvant chemotherapy plus tamoxifen compared with tamoxifen alone for postmenopausal breast cancer: meta-analysis of quality-adjusted survival

B. F. Cole, R. Gray, R. Gelber, 1996, The Lancet.

Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer.

M Baum, J Cuzick, B Fisher, 1988, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

The efficacy of bone scanning in the follow-up of patients with operable breast cancer

R. Foster, A. Glass, B. Fisher, 2005, Breast Cancer Research and Treatment.

Breast tumor recurrence following lumpectomy with and without breast irradiation: an overview of recent NSABP findings.

C. Redmond, D. Wickerham, B. Fisher, 1992, Seminars in surgical oncology.

Cooperative clinical trials in primary breast cancer: A critical appraisal

B. Fisher, 1973, Cancer.

Disease‐free survival at intervals during and following completion of adjuvant chemotherapy: The NSABP experience from three breast cancer protocols

C. Redmond, N. Wolmark, B. Fisher, 1981, Cancer.

Pathologic findings from the national surgical adjuvant breast project (protocol no. 4) vi. discriminants for five‐year treatment failure

C. Redmond, B. Fisher, E. Fisher, 1980, Cancer.

Tamoxifen for prevention of breast cancer.

B. Fisher, 1999, The Medical letter on drugs and therapeutics.

Pathologic findings from the national surgical adjuvant breast project (NSABP) protocol B‐17: Intraductal carcinoma (ductal carcinoma in situ)

J. Costantino, E. Mamounas, B. Fisher, 2006 .

Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.

C. Redmond, J. Costantino, D. Wickerham, 1994, Journal of the National Cancer Institute.

Tumor size and regional lymph node metastasis in colorectal cancer a preliminary analysis from the NSABP clinical trials

C. Redmond, N. Wolmark, B. Fisher, 1983, Cancer.

The technique of segmental mastectomy (lumpectomy) and axillary dissection: A syllabus from the National Surgical Adjuvant Breast Project workshops.

B. Fisher, R. Margolese, R. Poisson, 1987, Surgery.

Recent developments in the use of systemic adjuvant therapy for the treatment of breast cancer.

C. Redmond, D. Wickerham, B. Fisher, 1992, Seminars in oncology.

The Prognostic Significance of Preoperative Carcinoembryonic Antigen Levels in Colorectal Cancer: Results from NSABP Clinical Trials

N. Wolmark, B. Fisher, N. Dimitrov, 1984 .

The prognostic significance of tumor location and bowel obstruction in Dukes B and C colorectal cancer. Findings from the NSABP clinical trials.

H. Rockette, H. Wieand, N. Wolmark, 1983, Annals of surgery.

Tamoxifen for the prevention of breast cancer.

T. Powles, B. Fisher, K. Pritchard, 2000, European journal of cancer.

Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.

T. Julian, J. Costantino, N. Wolmark, 2011, Journal of the National Cancer Institute.

Surgical Adjuvant Chemotherapy in Cancer of the Breast: Results of a Decade of Cooperative Investigation

R K Ausman, G E Moore, B Fisher, 1968, Annals of surgery.

Adjuvant chemotherapy in stage II breast cancer: A brief overview of the NSABP clinical trials

N. Wolmark, B. Fisher, 1985, World Journal of Surgery.

United States trials of adjuvant therapy

B. Fisher, 1977, World Journal of Surgery.

Adjuvant therapy for breast cancer: a brief overview of the NSABP experience and some thoughts on neoadjuvant chemotherapy.

B. Fisher, 1986, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Adjuvant therapy in primary breast cancer.

N. Wolmark, B. Fisher, 1985, The Surgical clinics of North America.

The clinical scientific basis of adjuvant chemotherapy in breast cancer.

B. Fisher, 1984, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Impact of randomized clinical trials on therapy of primary breast cancer: the NSABP overview.

H. Rockette, C. Redmond, B. Fisher, 1982, Controlled Clinical Trials.

Adjuvant chemotherapy in breast cancer.

B. Fisher, 1978, International journal of radiation oncology, biology, physics.

Adjuvant chemotherapy in the primary management of breast cancer.

B. Fisher, 1977, The Medical clinics of North America.

Systemic Adjuvant (Combined Modality) Therapy in the Treatment of Primary Breast Cancer

N. Wolmark, B. Fisher, 1977 .

New concepts in the management of primary breast cancer

N. Wolmark, B. Fisher, N. Wolmark, 1975, Cancer.

Surgical adjuvant therapy for breast cancer

B. Fisher, 1972, Cancer.

The surgical dilemma in the primary therapy of invasive breast cancer: a critical appraisal.

B. Fisher, 1970, Current problems in surgery.

Systemic chemotherapy as an adjuvant to surgery in the treatment of breast cancer

B. Fisher, 1969, Cancer.

Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation.

Jong-Hyeon Jeong, Norman Wolmark, J. Bryant, 2002, The New England journal of medicine.

Findings from NSABP protocol no. B‐04‐comparison of radical mastectomy with alternative treatments for primary breast cancer. I. Radiation compliance and its relation to treatment outcome

C. Redmond, A. Zauber, B. Fisher, 1980, Cancer.

Prognosis among African‐American women and white women with lymph node negative breast carcinoma

C. Redmond, B. Edwards, J. Costantino, 1997, Cancer.

Association of tamoxifen and uterine sarcoma.

J. Bryant, J. Costantino, D. Wickerham, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The pathology of invasive breast cancer A Syllabus Derived from Findings of the National Surgical Adjuvant Breast Project (Protocol No. 4)

B. Fisher, E. Fisher, S. Sommers, 1975, Cancer.

Scar cancers: Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol No. 4) — IX

B. Fisher, E. Fisher, A. Palekar, 2005, Breast Cancer Research and Treatment.

Studies concerning the regional lymph node in cancer. VII. Thymidine uptake by cells from nodes of breast cancer patients relative to axillary location and histopathologic discriminants

B. Fisher, E. Fisher, E. Saffer, 1974, Cancer.

Location of breast carcinoma and prognosis.

R. Ausman, I. Bross, B. Fisher, 1969, Surgery, gynecology & obstetrics.

Adjuvant chemotherapy in stage-II breast cancer: An overview of the NSABP clinical trials

N. Wolmark, B. Fisher, Contributing Nsabp Investigators, 2005, Breast Cancer Research and Treatment.

The current status of systemic adjuvant therapy in the management of primary breast cancer.

N. Wolmark, B. Fisher, 1981, Surgical Clinics of North America.

Observations following Corynebacterium parvum administration to patients with advanced malignancy. A phase I study

N. Wolmark, B. Fisher, H. Rubin, 1976, Cancer.

Base-line quality-of-life assessment in the National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial.

C. Redmond, J. Ware, J. Ware, 1995, Journal of the National Cancer Institute.

Systemic therapy in patients with node-negative breast cancer. A commentary based on two National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials.

C. Redmond, D. Wickerham, N. Wolmark, 1989, Annals of internal medicine.

Re: tamoxifen prevention of breast cancer: an instance of the fingerpost.

B. Fisher, 2000, Journal of the National Cancer Institute.

The methodologic dilemma in retrospectively correlating the amount of chemotherapy received in adjuvant therapy protocols with disease-free survival.

C. Redmond, B. Fisher, H. Wieand, 1983, Cancer treatment reports.

Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

Mike Clarke, Yasuo Ohashi, Michael Gnant, 2018, The Lancet. Oncology.

Conservative surgery: the American experience.

N. Wolmark, B. Fisher, 1986, Seminars in oncology.

Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer.

B Fisher, J Costantino, C. Redmond, 1993, The New England journal of medicine.

Lumpectomy and axillary dissection for breast cancer: Surgical, pathological, and radiation considerations

N. Wolmark, B. Fisher, M. Deutsch, 1985, World Journal of Surgery.

Limited surgical management for primary breast cancer: A commentary on the NSABP reports

N. Wolmark, B. Fisher, 1985, World Journal of Surgery.

Surgical treatment of primary breast cancer.

D. Wickerham, B. Fisher, 1988, Seminars in surgical oncology.

Biological Implications of Breast Cancer Surgery

B. Fisher, 1986 .

Reappraisal of breast biopsy prompted by the use of lumpectomy. Surgical strategy.

B. Fisher, 1985, JAMA.

Re : Benzene and the Dose-Related Incidence of Hematologic Neoplasms in China

B. Fisher, J. Dignam, 1998 .

Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: results from the National Surgical Adjuvant Breast and Bowel Project B-16.

B Fisher, C. Redmond, D. Wickerham, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Systemic adjuvant therapy in treatment of primary operable breast cancer: National Surgical Adjuvant Breast and Bowel Project experience.

C. Redmond, N. Wolmark, B. Fisher, 1986, NCI monographs : a publication of the National Cancer Institute.

Occurrence of stroke with tamoxifen in NSABP B-24

B. Fisher, J. Dignam, 2000, The Lancet.

[The NSABP. National Surgical Adjuvant Project for Breast and Bowel Cancers. (Definition, role, methodology, therapeutic trials, results, philosophy)].

B. Fisher, R. Poisson, L. Perron, 1985, L'union medicale du Canada.

IS TAMOXIFEN A RISK FACTOR FOR RETINAL VASO-OCCLUSIVE DISEASE?

J. Costantino, D. Wickerham, N. Wolmark, 2005, Retina.

Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project

Norman Wolmark, N. Wolmark, E. Mamounas, 2004, Cancer.

Influence of tumor estrogen and progesterone receptor levels on the response to tamoxifen and chemotherapy in primary breast cancer.

C. Redmond, D. Wickerham, N. Wolmark, 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20.

S. Paik, G. Tang, S. Shak, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: results from the National Surgical Adjuvant Breast and Bowe

Anna L. Brown, C. Redmond, D. Wickerham, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer.

J. Costantino, C. Geyer, D. Wickerham, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Variation of macrophage migration by a factor from regional lymph node cells of breast cancer patients

B. Fisher, M. Kelly, R. Golinger, 1978, Cancer.

Survival after IBTR in NSABP Node Negative Protocols B-13, B-14, B-19, B-20 and B-23

J. Costantino, N. Wolmark, E. Mamounas, 2005 .

Pathologic findings from the national surgical adjuvant breast project (protocol 6). Relation of local breast recurrence to multicentricity

B. Fisher, E. Fisher, R. Sass, 1986, Cancer.

Five versus more than five years of tamoxifen for lymph node-negative breast cancer: updated findings from the National Surgical Adjuvant Breast and Bowel Project B-14 randomized trial.

J. Bryant, N. Wolmark, B. Fisher, 2001, Journal of the National Cancer Institute.

Paclitaxel after doxorubicin plus cyclophosphamide as adjuvant chemotherapy for node-positive breast cancer: results from NSABP B-28.

J. Bryant, D. Wickerham, N. Wolmark, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06.

C. Redmond, B. Fisher, E. Fisher, 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Acute toxicity during adjuvant chemotherapy for breast cancer: the National Surgical Adjuvant Breast and Bowel Project (NSABP) experience from 1717 patients receiving single and multiple agents.

C. Redmond, R. Foster, N. Wolmark, 1981, Cancer treatment reports.

Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17.

J. Costantino, D. Wickerham, N. Wolmark, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Highlights from recent National Surgical Adjuvant Breast and Bowel Project studies in the treatment and prevention of breast cancer

B. Fisher, 1999, CA: a cancer journal for clinicians.

Estrogen receptor status of primary breast cancer is predictive of estrogen receptor status of contralateral breast cancer.

Norman Wolmark, S. Paik, J. Bryant, 2004, Journal of the National Cancer Institute.

The effect of a single and repeated administration of Corynebacterium parvum on bone marrow macrophage colony production in normal mice.

N. Wolmark, B. Fisher, M. Levine, 1974, Journal of the Reticuloendothelial Society.

The place of neck dissection in the management of parotid tumors.

B. Fisher, S. Perzik, 1970, American journal of surgery.

Vincristine is Associated with the Risk of Azoospermia in Adult Male Survivors of Childhood Malignancies

C. Redmond, B. Fisher, Wickerham Dl, 1992 .

The incidence of lung carcinoma after surgery for breast carcinoma with and without postoperative radiotherapy

N. Wolmark, B. Fisher, M. Begovic, 2003, Cancer.

Role of science in the treatment of breast cancer when tumor multicentricity is present.

B. Fisher, 2011, Journal of the National Cancer Institute.

Biological research in the evolution of cancer surgery: a personal perspective.

B. Fisher, 2008, Cancer research.

From Halsted to prevention and beyond: advances in the management of breast cancer during the twentieth century.

B. Fisher, 1999, European journal of cancer.

Biological and clinical considerations regarding the use of surgery and chemotherapy in the treatment of primary breast cancer

B. Fisher, 1977, Cancer.

The Changing Role of Surgery in the Treatment of Cancer

B. Fisher, 1977 .

The effect of a single and repeated administration of Corynebacterium parvum on bone marrow macrophage colony production in syngeneic tumor-bearing mice.

N. Wolmark, B. Fisher, 1974, Cancer research.

Relation of estrogen and/or progesterone receptor content of breast cancer to patient outcome following adjuvant chemotherapy

H. Rockette, C. Redmond, D. Wickerham, 2005, Breast Cancer Research and Treatment.

Surgery of Primary Breast Cancer

B. Fisher, 1977 .

Correlation of antitumor chemoimmunotherapy with bone marrow macrophage precursor cell stimulation and macrophage cytotoxicity.

N. Wolmark, B. Fisher, 1976, Cancer research.

Role of murine tumor models in cancer treatment research.

P. Houghton, B. Fisher, J. Houghton, 1986, Cancer research.

Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials

Bingshu E. Chen, D. Berry, P. Fasching, 2019, The Lancet.

Breast-Cancer Management

B. Fisher, 1979 .

Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial.

T. Walsh, M. King, L. Ford, 2001, JAMA.

National Surgical Adjuvant Breast and Bowel Project

B. Fisher, Bernard Fisher, N. Wolmark, 2020, Definitions.

Breast cancer estrogen and progesterone receptor values: their distribution, degree of concordance, and relation to number of positive axillary nodes.

C. Redmond, D. Wickerham, B. Fisher, 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Findings from recent National Surgical Adjuvant Breast and Bowel Project adjuvant studies in stage I breast cancer.

D. Wickerham, N. Wolmark, E. Mamounas, 2001, Journal of the National Cancer Institute. Monographs.

Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) protocol B‐17: Five‐year observations concerning lobular carcinoma in situ

S. Paik, B. Fisher, E. Fisher, 1996, Cancer.

Pathologic findings from the national surgical adjuvant project for breast cancers (protocol no. 4) X. Discriminants for tenth year treatment failure

B. Fisher, E. Fisher, R. Sass, 1984, Cancer.

Ten year follow-up results of patients with carcinoma of the breast in a co-operative clinical trial evaluating surgical adjuvant chemotherapy.

N. Wolmark, B. Fisher, N. Slack, 1975, Surgery, gynecology & obstetrics.

Cancer of the breast: Size of neoplasm and prognosis

I D Bross, B Fisher, I. Bross, 1969, Cancer.

Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation.

B Fisher, C. Redmond, R. Foster, 1985, The New England journal of medicine.

Local therapy and survival in breast cancer.

B. Fisher, S. Anderson, 2007, The New England journal of medicine.

Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.

Jong-Hyeon Jeong, Norman Wolmark, J. Bryant, 2002, The New England journal of medicine.

Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01.

H. Rockette, C. Redmond, D. Wickerham, 1988, Journal of the National Cancer Institute.

Correlation of estrogen receptor and pathologic characteristics of invasive breast cancer

H. Rockette, C. Redmond, B. Fisher, 1980, Cancer.

Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight‐year update of Protocol B‐17

J Costantino, S. Paik, B. Fisher, 1999, Cancer.

Laboratory and clinical research in breast cancer--a personal adventure: the David A. Karnofsky memorial lecture.

B. Fisher, 1980, Cancer research.

A perspective concerning the relation of duration of symptoms to treatment failure in patients with breast cancer

C. Redmond, B. Fisher, E. Fisher, 1977, Cancer.

A comparison of stapled and handsewn anastomoses in patients undergoing resection for Dukes' B and C colorectal cancer

N. Wolmark, B. Fisher, P. gordon, 1986, Diseases of the colon and rectum.

Pathobiology of small invasive breast cancers without metastases (T1a/b, N0, M0)

J. Costantino, N. Wolmark, B. Fisher, 2007, Cancer.

Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update

C. Redmond, R. Foster, D. Wickerham, 1983, Cancer.

Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer.

B Fisher, C. Redmond, N. Wolmark, 1989, The New England journal of medicine.

Eight-year Results of a Randomized Clinical Trial Comparing Total Mastectomy and Lumpectomy with or without Irradiation in the Treatment of Breast Cancer

C. Redmond, N. Wolmark, A. Glass, 1989 .

Status of adjuvant therapy. Results of the national surgical adjuvant breast project studies on oophorectomy, postoperative radiation therapy, and chemotherapy. Other comments concerning clinical trials

B. Fisher, B. Fisher, 1971, Cancer.

Results of a clinical trial concerning the worth of prophylactic oophorectomy for breast carcinoma.

B. Fisher, N. Slack, B. Gardner, 1970, Surgery, gynecology & obstetrics.

Doxorubicin-containing regimens for the treatment of stage II breast cancer: The National Surgical Adjuvant Breast and Bowel Project experience.

C. Redmond, D. Wickerham, N. Wolmark, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Some thoughts concerning the primary therapy of breast cancer.

B. Fisher, 1976, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Tamoxifen and chemotherapy for axillary node-negative, estrogen receptor-negative breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-23.

D. Wickerham, N. Wolmark, S. Anderson, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.

L. Ford, J. Costantino, D. Wickerham, 2005, Journal of the National Cancer Institute.

Pathologic findings from the national surgical adjuvant breast project (protocol no. 4). V. significance of axillary nodal micro‐ and macrometastases

H. Rockette, C. Redmond, B. Fisher, 1978, Cancer.

Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer:National Surgical Adjuvant Breast and Bowel Project Protocol B-27.

Norman Wolmark, Soonmyung Paik, S. Paik, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pathobiology of preoperative chemotherapy

J. Bryant, N. Wolmark, B. Fisher, 2002 .

Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer.

C. Redmond, D. Wickerham, N. Wolmark, 1995, New England Journal of Medicine.

Fraud in breast-cancer trials.

C. Redmond, B. Fisher, 1994, The New England journal of medicine.

erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer.

B Fisher, S. Paik, J. Bryant, 1998, Journal of the National Cancer Institute.

Pathologic variables predictive of breast events in patients with ductal carcinoma in situ.

J. Costantino, D. Wickerham, N. Wolmark, 2007, American journal of clinical pathology.

Adjuvant tamoxifen and chemotherapy in stage II breast cancer: Interim findings from NSABP protocol B-09

N. Wolmark, B. Fisher, 1985, World Journal of Surgery.

Tumor nuclear grade, estrogen receptor, and progesterone receptor: Their value alone or in combination as indicators of outcome following adjuvant therapy for breast cancer

C. Redmond, B. Fisher, E. Fisher, 2005, Breast Cancer Research and Treatment.

Treatment of primary breast cancer with L-PAM/5-FU and tamoxifen: An interim report

B. Fisher, other Nsabp investigators, 2005, Breast Cancer Research and Treatment.

Treatment of axillary lymph node-negative, estrogen receptor-negative breast cancer: updated findings from National Surgical Adjuvant Breast and Bowel Project clinical trials.

N. Wolmark, B. Fisher, Jong-Hyeon Jeong, 2004, Journal of the National Cancer Institute.

S-phase fraction combined with other patient and tumor characteristics for the prognosis of node-negative, estrogen- receptor-positive breast cancer

J. Bryant, J. Costantino, B. Fisher, 2004, Breast Cancer Research and Treatment.

Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience.

N. Wolmark, E. Mamounas, B. Fisher, 2001, Seminars in oncology.

Further evaluation of intensified and increased total dose of cyclophosphamide for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-25.

D. Wickerham, N. Wolmark, S. Anderson, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Evaluation of the worth of Corynebacterium parvum in conjunction with chemotherapy as adjuvant treatment for primary breast cancer: Eight‐year results from the national surgical adjuvant breast and bowel project B‐10

C. Redmond, R. Foster, D. Wickerham, 1990, Cancer.

Prolonging tamoxifen therapy for primary breast cancer. Findings from the National Surgical Adjuvant Breast and Bowel Project clinical trial.

C. Redmond, D. Wickerham, N. Wolmark, 1987, Annals of internal medicine.

Adjuvant chemotherapy with and without tamoxifen in the treatment of primary breast cancer: 5-year results from the National Surgical Adjuvant Breast and Bowel Project Trial.

C. Redmond, N. Wolmark, B. Fisher, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Leukemia in breast cancer patients following adjuvant chemotherapy or postoperative radiation: the NSABP experience.

H. Rockette, C. Redmond, D. Wickerham, 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Findings from NSABP protocol no. b‐04: Comparison of radical mastectomy with alternative treatments. II. The clinical and biologic significance of medial‐central breast cancers

C. Redmond, B. Fisher, E. Fisher, 1981, Cancer.

Comparison of radical mastectomy with alternative treatments for primary breast cancer

C. Redmond, B. Fisher, R. Margolese, 1978 .

Comparison of radical mastectomy with alternative treatments for primary breast cancer: A first report of results from a prospective randomized clinical trial

Eleanor Montague, Harvey Butcher, C. Redmond, 1977 .

J. Costantino, D. Wickerham, P. Ganz, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials.

C. Geyer, N. Wolmark, E. Mamounas, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The evolution of paradigms for the management of breast cancer: a personal perspective.

B. Fisher, 1992, Cancer research.

Tamoxifen a nd C hemotherapy f or A xillary N ode-Negative, Estrogen R eceptor-Negativ e B reast C ancer: F indings F rom National S urgical A djuvant B reast a nd B owel P roject B -23

D. Wickerham, N. Wolmark, B. Fisher, 2001 .

Solving the dilemma of the immunohistochemical and other methods used for scoring estrogen receptor and progesterone receptor in patients with invasive breast carcinoma

C. Geyer, N. Wolmark, D. Dabbs, 2005, Cancer.

The Prognostic Significance of Tumor Location and Bowel Obstruction in Dukes B and C Colorectal Cancer

H. Rockette, N. Wolmark, A. Glass, 1983 .

The Prognostic Value of the Modifications of the Dukes' C Class of Colorectal Cancer: An Analysis of the NSABP Clinical Trials

N. Wolmark, B. Fisher, H. Wieand, 1986, Annals of surgery.

Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27.

T. Julian, D. Wickerham, N. Wolmark, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of primary breast cancer with chemotherapy and tamoxifen.

C. Redmond, N. Wolmark, B. Fisher, 1981, The New England journal of medicine.

Pathologic findings from the national surgical adjuvant breast project (protocol no. 4): XI. Bilateral breast cancer

B. Fisher, E. Fisher, R. Sass, 1984, Cancer.

Fifteen‐year prognostic discriminants for invasive breast carcinoma

B Fisher, B. Fisher, E. Fisher, 2001, Cancer.

The operative management of primary breast cancer.

B. Fisher, 1977, International journal of radiation oncology, biology, physics.

DNA flow cytometric analysis of primary operable breast cancer. Relation of ploidy and S‐Phase fraction to outcome of patients in NSABP B‐04

C. Redmond, B. Fisher, E. Fisher, 1991, Cancer.

Pathologic findings from the national surgical adjuvant breast project protocol B‐06 10‐year pathologic and clinical prognostic discriminants

C. Redmond, B. Fisher, B. Fisher, 1993, Cancer.

Preoperative chemotherapy for operable breast cancer.

E. Mamounas, B. Fisher, E. Mamounas, 2000, Cancer treatment and research.

The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast.

C. Redmond, N. Wolmark, B. Fisher, 1981, Surgery, gynecology & obstetrics.

The breast cancer alternative hypothesis: is there evidence to justify replacing it?

B. Fisher, S. Anderson, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Detection and significance of occult axillary node metastases in patients with invasive breast cancer

H. Rockette, C. Redmond, B. Fisher, 1978, Cancer.

Postoperative Radiotherapy in the Treatment of Breast Cancer: Results of the NSABP Clinical Trial

B. Fisher, N. Slack, P. Cavanaugh, 1970, Annals of surgery.

Pathologic findings from the national surgical adjuvant breast project (protocol no. 4). I. Observations concerning the multicentricity of mammary cancer

C. Redmond, B. Fisher, E. Fisher, 1975, Cancer.

Experiences with bilateral primary carcinoma of the breast.

I. Bross, B. Fisher, T. Nemoto, 1973, Surgery, gynecology & obstetrics.

Preoperative (neoadjuvant) chemotherapy in patients with breast cancer.

E. Mamounas, B. Fisher, 2001, Seminars in oncology.

Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation

B Fisher, B. Fisher, 1986 .

1‐Phenylalanine mustard (L‐PAM) in the management of premenopausal patients with primary breast cancer. Lack of association of disease‐free survival with depression of ovarian function

H. Rockette, C. Redmond, B. Fisher, 1979, Cancer.

L‐phenylalanine mustard (L‐PAM) in the management of primary breast cancer: An update of earlier findings and a comparison with those utilizing L‐PAM plus 5‐fluorouracil (5‐FU)

C. Redmond, R. Foster, A. Glass, 1977, Cancer.

Preoperative chemotherapy: a model for studying the biology and therapy of primary breast cancer.

E. Mamounas, B. Fisher, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long-term tamoxifen citrate use and potential ocular toxicity.

C. Redmond, J. Costantino, N. Wolmark, 1998, American journal of ophthalmology.

The contribution of recent nsabp clinical trials of primary breast cancer therapy to an understanding of tumor biology—an overview of findings

C. Redmond, B. Fisher, E. Fisher, 1980, Cancer.

Therapy of breast cancer

A. Forrest, B. Fisher, C. Herfarth, 1978, Langenbecks Archiv für Chirurgie.

The revolution in breast cancer surgery: Science or anecdotalism?

B. Fisher, Bernard Fisher, 1985, World Journal of Surgery.

Tamoxifen Use , and Outcomes in Women With Estrogen Receptor – Positive Early-Stage Breast Cancer

E. Mamounas, B. Fisher, J. Dignam, 2003 .

Conservative surgery for the management of invasive and noninvasive carcinoma of the breast: NSABP trials

B. Fisher, S. Anderson, 2004, World Journal of Surgery.

Tamoxi fen , Radiat ion Therapy , or Both for Prevent ion of Ips i la tera l Breast Tumor Recurrence Af ter Lumpectomy in Women With Invas ive Breast Cancers of One Cent imeter or Less

S. Paik, J. Bryant, D. Wickerham, 2002 .

Fluoresceinated estrone binding by cells from human breast cancers obtained by needle aspiration

B. Fisher, N. Gunduz, Shu Zheng, 1983, Cancer.

Pathologic findings from the national surgical adjuvant breast project. VIII. Relationship of chemotherapeutic responsiveness to tumor differentiation

C. Redmond, B. Fisher, E. Fisher, 1983, Cancer.

The significance of concordance in mammographic interpretations

D Gur, B Fisher, D. Gur, 1979, Cancer.

An Analysis of Survival and Treatment Failure Following Abdominoperineal and Sphincter‐saving Resection in Dukes' B and C Rectal Carcinoma: A Report of the NSABP Clinical Trials

N. Wolmark, B. Fisher, 1986, Annals of surgery.

J. Kopec, G. Tang, N. Wolmark, 2004, Breast Cancer Research and Treatment.

Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer.

J. Cuzick, R. Peto, B. Fisher, 1987, Cancer treatment reports.

Early stopping of a clinical trial when there is evidence of no treatment benefit: protocol B-14 of the National Surgical Adjuvant Breast and Bowel Project.

B Fisher, J. Bryant, N. Wolmark, 1998, Controlled clinical trials.

Clinical trials for the evaluation of cancer therapy

B. Fisher, 1984, Cancer.

Adjuvant 5-fluorouracil and leucovorin with or without interferon alfa-2a in colon carcinoma: National Surgical Adjuvant Breast and Bowel Project protocol C-05.

J. Bryant, N. Wolmark, J. Grem, 1998, Journal of the National Cancer Institute.

Evolution of knowledge related to breast cancer heterogeneity: a 25-year retrospective.

C. Redmond, B. Fisher, E. Fisher, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A biological perspective of breast cancer: Contributions of the national surgical adjuvant breast and bowel project clinical trials

B. Fisher, 1991, CA: a cancer journal for clinicians.

Adjuvant chemotherapy for breast cancer: an overview of NSABP findings.

C. Redmond, R. Foster, B. Fisher, 1982, International advances in surgical oncology.

Systemic therapy in node-negative patients: updated findings from NSABP clinical trials. National Surgical Adjuvant Breast and Bowel Project.

C. Redmond, B. Fisher, 1992, Journal of the National Cancer Institute. Monographs.

Commentary on endometrial cancer deaths in tamoxifen-treated breast cancer patients.

B. Fisher, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. III. Effect of C. parvum on cyclophosphamide metabolism.

N. Wolmark, B. Fisher, H. Rubin, 1976, Journal of the National Cancer Institute.

Further observations on the inhibition of tumor growth by corynebacterium parvum with cyclophosphamide.

N. Wolmark, B. Fisher, H. Rubin, 1976, Journal of the National Cancer Institute.

Current Controversies in Cancer Tamoxifen for the prevention of breast cancer

B. Fisher, 2000 .

A commentary on the role of the surgeon in primary breast cancer

B. Fisher, 2005, Breast Cancer Research and Treatment.

Surgery in the primary treatment of breast cancer

N. Wolmark, B. Fisher, 2005, Breast Cancer Research and Treatment.

A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum

H. Rockette, N. Petrelli, H. Wieand, 1997, Diseases of the colon and rectum.

Lumpectomy versus quadrantectomy for breast conservation: a critical appraisal.

B. Fisher, 1995, European journal of cancer.

The evolution of breast cancer surgery: past, present, and future.

B. Fisher, M. Gebhardt, 1978, Seminars in Oncology.

Breast‐Conserving Surgery in the Treatment of Invasive Breast Cancer: Its Validity and Outstanding Issues

B. Fisher, 1995 .

On the underutilization of breast-conserving surgery for the treatment of breast cancer.

B. Fisher, L. Ore, 1993, Annals of oncology : official journal of the European Society for Medical Oncology.

Justification for lumpectomy in the treatment of breast cancer: a commentary on the underutilization of that procedure.

B. Fisher, 1992, Journal of the American Medical Women's Association.

A vignette from breast cancer history: one hundred years after the Greenough report.

B. Fisher, 2005, Journal of the American College of Surgeons.

One Giant Leap for Mankind

B. Fisher, 1973 .

Dukes' classification revisited. Findings from the national surgical adjuvant breast and bowel projects (protocol r‐01)

N. Wolmark, B. Fisher, E. Fisher, 1989 .

Leukemia in Breast Cancer Patients Following Adjuvant Chemotherapy or Postoperative Radiation

H. Rockette, C. Redmond, D. Wickerham, 2016 .

Sounding board. Breast-cancer management: alternatives to radical mastectomy.

B. Fisher, 1979, The New England journal of medicine.

Tamoxifen for intraductal cancer

B. Fisher, J. Dignam, 1999, The Lancet.

A Personal Perspective About the Future of Breast Cancer Research and Treatment

B. Fisher, 2000 .

Postoperative adjuvant chemotherapy or BCG for colon cancer: results from NSABP protocol C-01.

H. Rockette, C. Redmond, D. Wickerham, 1988, Journal of the National Cancer Institute.

Prognostic significance of eosinophils and mast cells in rectal cancer: findings from the National Surgical Adjuvant Breast and Bowel Project (protocol R-01).

H. Rockette, S. Paik, B. Fisher, 1989, Human pathology.

The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03.

H. Rockette, C. Redmond, N. Petrelli, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18.

D. Wickerham, N. Wolmark, E. Mamounas, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02.

H. Rockette, N. Petrelli, D. Wickerham, 2000, Journal of the National Cancer Institute.

Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project C-04.

H. Rockette, D. Wickerham, N. Wolmark, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer

J. Bryant, D. Wickerham, H. Bear, 2023, Journal of Clinical Oncology.

Pathologic findings from the National Surgical Adjuvant Breast Project (protocol no. 4). VI. Invasive papillary cancer.

C. Redmond, B. Fisher, B. Fisher, 1980, American journal of clinical pathology.

Pathologic findings from the national surgical adjuvant breast project (protocol 6) I. Intraductal carcinoma (DCIS)

S. Paik, B. Fisher, B. Fisher, 1986, Cancer.

Significance of ipsilateral breast tumour recurrence after lumpectomy

C. Redmond, D. Wickerham, N. Wolmark, 1991, The Lancet.

Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

S. Steinberg, E. Rutgers, E. Winer, 2018, The Lancet. Oncology.

The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer.

H E Rockette, H. Rockette, P. Johnston, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II study of the progesterone antagonist mifepristone in patients with untreated metastatic breast carcinoma: a National Cancer Institute of Canada Clinical Trials Group study.

E. Eisenhauer, B. Fisher, B. Norris, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adjuvant therapy of Dukes' A, B, and C adenocarcinoma of the colon with portal-vein fluorouracil hepatic infusion: preliminary results of National Surgical Adjuvant Breast and Bowel Project Protocol C-02.

H. Rockette, C. Redmond, D. Wickerham, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pathologic findings from the national surgical adjuvant breast and bowel project: Twelve-year observations concerning lobular carcinoma in situ

B. Fisher, L. Middleton, E. Fisher, 2004 .

Preoperative (neoadjuvant) chemotherapy in patients with breast cancer.

B. Fisher, E. Mamounas, 2001, Seminars in oncology.

Effect of local or systemic treatment prior to primary tumor removal on the production and response to a serum growth-stimulating factor in mice.

B. Fisher, B. Fisher, N. Gunduz, 1989, Cancer research.

Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18.

J. Bryant, B. Fisher, Jiping Wang, 2001, Journal of the National Cancer Institute. Monographs.

Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer.

Ronin, C. Redmond, D. Wickerham, 1995, The New England journal of medicine.

National Surgical Adjuvant Breast and Bowel Project

B. Fisher, 2005 .

Chemotherapy and tamoxifen for breast cancer.

C. Redmond, N. Wolmark, B. Fisher, 1981, The New England journal of medicine.

Surgery for early breast cancer.

C. Redmond, B. Fisher, S. Anderson, 1996, The New England journal of medicine.

Adjuvant therapy in node-negative breast cancer

W. McGuire, C. Osborne, J. Glick, 1989, Breast Cancer Research and Treatment.

Association of tamoxifen and uterine sarcoma.

J. Bryant, J. Costantino, D. Wickerham, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Investigation of disease-free survival as a surrogate endpoint for survival in cancer clinical trials

H. Wieand, A. Lindblad, B. Fisher, 1998 .